Clinical Trials Logo

Clinical Trial Summary

To asses prevalence of pathological findings in patients with chronic diarrhea and normal colonoscopy


Clinical Trial Description

diarrhea is defined as the of 3 or more loose or liquid stools per day, or more frequently than is normal for the individual. 3. (World Health ion. Diarrhoeal disease .Available 2017) Diarrhea can be separated into acute, persistent and chronic types based on duration. Acute diarrhea lasts less than 14 days whereas persistent diarrhea is longer than 14 days, but no longer than 28 days( Zilla GC, Israel EJ. et al ..2012) Chronic diarrhea than 28 days. (Schiller LR, Parda DS, et al..2017) In addition to duration of symptoms, chronic diarrhea also tends to occur without a clear onset whereas persistent diarrhea can be thought of as an acute process that has persisted for a longer period.( zilla GC, Israel EJ. et al ..2012) it can be secondary to such heterogeneous causes as drug side effects, structural abnormalities of the small bowel and/or colon, the result of previous gastrointestinal surgery, inflammatory or neo-plastic pancreato biliary disease, or as part of an intestinal functional disorder, such as functional diarrhea, or irritable bowel syndrome (IBS) that is diarrhea predominant (IBS-D)or post infectious (PI-IBS) ( Burgers K, Lindberg B, 2020) or Primary eosinophilic colitis (PEC) is defined as an inflam-matory disease of unknown etiology that mainly manifests as abdominal pain and diarrhea, segmental or diffuse infil-tration of eosinophils in the mucosa of the colon,( Villanueva MS, Alimi Y.et al ..2015)( Impellizzeri G, Marasco G ,et al ..2019) or Enteropathies( are diseases that affect small bowel (SB) function and clinically manifest as chronic diarrhea).( Jansson-Knodell CL, Hujoel IA, et al 2017) as Monomorphic epitheliotropic intestinal T-cell lymphoma(MEITL) is a rare aggressive disease that mainly affects the SuB mucosa. Its symptoms can be nonspecific, but often presents chronic diarrhea (Ramírez-Quintero JD, Carvajal JJ,et al..2021) Evaluation of the colonic mucosa is very helpful in detecting inflam-matory bowel disease, ischemic colitis, microscopic colitis, neoplasis, and intraepithelial infections. The endoscopic appearance of the colon is normal, or almost normal, in some of those diseases, and thus they can go by un detected .Different studies have shown that systematic endoscopic biopsies of the colon provide good diagnostic yield in patients with chronic non inflammatory diarrhea and normal colonoscopy (López-Valenzuela LA, Murcio-Pérez E, et al..2019) chronic inflammatory disorder of the large intestine that mainly affects the elderly. Microscopic colitis differs from classical inflammatory bowel disease (IBD) in its almost normal-appearing colonic mucosa and histological findings consistent with increased lymphocytic infiltrates with or without collagen fiber expansion (Khalili et al., 2020). Microscopic colitis has two major subtypes, lymphocytic colitis (LC) and collagenous colitis (CC) (Shor et al., 2019) chronic watery diarrhea and often have no weight loss These forms of colitis also have an entirely of normal endoscopic appearance (Macaigne et al., 2014). If colonoscopy is done in patients suspected of having IBS-D, random colon biopsies should be done to rule out , structural abnormalities of the small bowel and/or colon, the result of previous gastrointestinal surgery, inflammatory or neo-plastic pancreato biliary disease, or as part of an intestinal functional disorder, such as functional diarrhea, or irritable bowel syndrome (IBS) that is diarrhea predominant (IBS-D)or post infectious (PI-IBS) ( Burgers K, Lindberg B, 2020) or Primary eosinophilic colitis and microscopic colitis (Münch et al., 2020). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05811091
Study type Observational
Source Assiut University
Contact Esraa Mansour Omar
Phone 01140285103
Email asramnswr82@gmail.com
Status Not yet recruiting
Phase
Start date March 5, 2024
Completion date May 5, 2024

See also
  Status Clinical Trial Phase
Completed NCT03269305 - An Audit on Management of Chronic Diarrhea
Completed NCT03876717 - Effect of the Sequestrant Colesevelam in Bile Acid Diarrhoea Phase 4
Not yet recruiting NCT03598010 - Safety, Tolerability and Preliminary Efficacy of Lenodiar Pediatric in Diarrhea N/A
Completed NCT05690321 - Opium Tincture Against Chronic Diarrhea - Patients Phase 2
Terminated NCT01866774 - Evaluation of Fecal Calprotectin Screening and a Gastroenterology Questionnaire for Triaging Children With Chronic Abdominal Pain and/or Diarrhea Referred to a Pediatric Gastroenterology Service N/A
Completed NCT01545063 - CAre of Patients With PArenteral Nutrition At Home N/A
Completed NCT05702190 - Opium Tincture Against Chronic Diarrhea - Healthy N/A
Not yet recruiting NCT05724381 - Auramine Phenol Staining Technique for Revealing Different Coccidian Parasites
Recruiting NCT01070277 - Antiparasitic Treatment for Returning Travelers With Chronic Diarrhea N/A
Completed NCT02642250 - Comparative Evaluation of Herbal and Allopathic Drugs for the Treatment of Chronic Diarrhea Phase 2/Phase 3
Recruiting NCT06152289 - Development of New Diagnostic Tools in Capsule Endoscopy
Completed NCT03270085 - Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid Malabsorption Phase 2
Completed NCT05130047 - Aldafermin (NGM282) for Chronic Diarrhea Due to Bile Acid Malabsorption (BAM) Phase 2
Recruiting NCT03261297 - Epidemiology of Chronic Diarrhea Among Children Admitted to Gastroenterology Unit at Assuit University Children Hospital N/A
Completed NCT01840891 - Secondary Lactose Intolerance Due to Chronic Norovirus Infection N/A
Completed NCT03143517 - Fecal Calprotectin Collection Protocol